See also this year's filing and all EDGAR filings for this company.
PDF Report 0001316175_2016_Anthera_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001316175, Anthera Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 47,862,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 263,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 8,468,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,568,000 |
| 9 | ResearchAndDevelopmentExpense | 33,498,000 |
| 10 | remainder_Expenses | -2,638,000 |
| 11 | remainder_Revenues | 3,185,000 |
| 12 | remainder_NetIncome | 23,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,125,000 |
| 1 | Liabilities | 8,468,000 |
| 2 | Expenses | 38,428,000 |
| 3 | Revenues | 3,185,000 |
| 4 | StockholdersEquity | 39,657,000 |
| 5 | NetIncome | -35,220,000 |
| 6 | ComprehensiveNetIncome | -35,220,000 |
| 7 | BaseVar | 49,114,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.81 |
| 9 | EconomicCapitalRatio | 2.90 |
Edgar->Model Mapping
Feature Distribution
Change over Time
